FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069510249> ?p ?o ?g. }

• W2069510249 endingPage "252" @default.
• W2069510249 startingPage "242" @default.
• W2069510249 abstract "Objectives Accumulation of advanced glycation end products (AGEs) has been linked to many of the complications of diabetes mellitus, including erectile dysfunction (ED). Furthermore, it has been demonstrated that inhibitors of AGE formation, such as aminoguanidine, can prevent ED in diabetic animals. However, it is unknown whether late administration of a putative cross‐link breaker, ALT‐711, can reverse diabetic ED. We therefore compared ALT‐711 and aminoguanidine in their ability to reverse ED in diabetic rats. Materials and Methods Male Sprague–Dawley rats were randomly divided into four groups: (i) age‐matched controls; (ii) streptozotocin (STZ)‐induced diabetic rats (60 mg/kg; intraperitoneal injection); (iii) STZ diabetic rats treated with ALT‐711 (3 mg/kg/day, intraperitoneal injection); and (iv) STZ diabetic rats treated with aminoguanidine (1 gm/L in drinking water) during the final 6 weeks of 12 weeks of induced diabetes. At the end of 12 weeks, erectile response to cavernous nerve stimulation (CNS) was determined. Neuronal nitric oxide synthase (nNOS) contents were measured in all penises, and AGE levels were determined both in penile tissues and in serum samples. Results Erectile responses to CNS and penile nNOS protein content were significantly reduced, while AGE levels were elevated in the penises and serum of untreated diabetic animals. Treatment with ALT‐711, but not with aminoguanidine, reversed ED and nNOS depletion and reduced serum and penile tissue AGE levels. Conclusions . These results suggest that cross‐link breakers, such as ALT‐711, are the optimal therapeutic approach, compared with treatment with inhibitors of AGE formation, in the reversal of diabetes‐related ED. Usta MF, Kendirci M, Gur S, Foxwell NA, Bivalacqua TJ, Cellek S, and Hellstrom WJG. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin‐induced diabetic rats: Preventive versus curative treatment. J Sex Med 2006;3:242–252." @default.
• W2069510249 created "2016-06-24" @default.
• W2069510249 creator A5012493488 @default.
• W2069510249 creator A5017136849 @default.
• W2069510249 creator A5022876140 @default.
• W2069510249 creator A5061390910 @default.
• W2069510249 creator A5072348280 @default.
• W2069510249 creator A5077350606 @default.
• W2069510249 creator A5079427154 @default.
• W2069510249 date "2006-03-01" @default.
• W2069510249 modified "2023-10-03" @default.
• W2069510249 title "The Breakdown of Preformed Advanced Glycation End Products Reverses Erectile Dysfunction in Streptozotocin‐Induced Diabetic Rats: Preventive Versus Curative Treatment" @default.
• W2069510249 cites W1968813770 @default.
• W2069510249 cites W1974995296 @default.
• W2069510249 cites W1986699779 @default.
• W2069510249 cites W2012365138 @default.
• W2069510249 cites W2044116965 @default.
• W2069510249 cites W2052103657 @default.
• W2069510249 cites W2070601048 @default.
• W2069510249 cites W2077837963 @default.
• W2069510249 cites W2080185912 @default.
• W2069510249 cites W2086204200 @default.
• W2069510249 cites W2097474009 @default.
• W2069510249 cites W2098933502 @default.
• W2069510249 cites W2106893238 @default.
• W2069510249 cites W2107516773 @default.
• W2069510249 cites W2129938192 @default.
• W2069510249 cites W2135816525 @default.
• W2069510249 cites W2136262455 @default.
• W2069510249 cites W2138453316 @default.
• W2069510249 cites W2146655079 @default.
• W2069510249 cites W2159602704 @default.
• W2069510249 cites W2297358297 @default.
• W2069510249 cites W3184768937 @default.
• W2069510249 doi "https://doi.org/10.1111/j.1743-6109.2006.00217.x" @default.
• W2069510249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16490017" @default.
• W2069510249 hasPublicationYear "2006" @default.
• W2069510249 type Work @default.
• W2069510249 sameAs 2069510249 @default.
• W2069510249 citedByCount "57" @default.
• W2069510249 countsByYear W20695102492012 @default.
• W2069510249 countsByYear W20695102492013 @default.
• W2069510249 countsByYear W20695102492014 @default.
• W2069510249 countsByYear W20695102492015 @default.
• W2069510249 countsByYear W20695102492016 @default.
• W2069510249 countsByYear W20695102492017 @default.
• W2069510249 countsByYear W20695102492018 @default.
• W2069510249 countsByYear W20695102492019 @default.
• W2069510249 countsByYear W20695102492020 @default.
• W2069510249 countsByYear W20695102492021 @default.
• W2069510249 countsByYear W20695102492022 @default.
• W2069510249 crossrefType "journal-article" @default.
• W2069510249 hasAuthorship W2069510249A5012493488 @default.
• W2069510249 hasAuthorship W2069510249A5017136849 @default.
• W2069510249 hasAuthorship W2069510249A5022876140 @default.
• W2069510249 hasAuthorship W2069510249A5061390910 @default.
• W2069510249 hasAuthorship W2069510249A5072348280 @default.
• W2069510249 hasAuthorship W2069510249A5077350606 @default.
• W2069510249 hasAuthorship W2069510249A5079427154 @default.
• W2069510249 hasConcept C126322002 @default.
• W2069510249 hasConcept C134018914 @default.
• W2069510249 hasConcept C147990577 @default.
• W2069510249 hasConcept C2776553924 @default.
• W2069510249 hasConcept C2776997535 @default.
• W2069510249 hasConcept C2778198053 @default.
• W2069510249 hasConcept C2778797674 @default.
• W2069510249 hasConcept C2779280383 @default.
• W2069510249 hasConcept C2779929075 @default.
• W2069510249 hasConcept C2780159080 @default.
• W2069510249 hasConcept C519581460 @default.
• W2069510249 hasConcept C555293320 @default.
• W2069510249 hasConcept C71924100 @default.
• W2069510249 hasConceptScore W2069510249C126322002 @default.
• W2069510249 hasConceptScore W2069510249C134018914 @default.
• W2069510249 hasConceptScore W2069510249C147990577 @default.
• W2069510249 hasConceptScore W2069510249C2776553924 @default.
• W2069510249 hasConceptScore W2069510249C2776997535 @default.
• W2069510249 hasConceptScore W2069510249C2778198053 @default.
• W2069510249 hasConceptScore W2069510249C2778797674 @default.
• W2069510249 hasConceptScore W2069510249C2779280383 @default.
• W2069510249 hasConceptScore W2069510249C2779929075 @default.
• W2069510249 hasConceptScore W2069510249C2780159080 @default.
• W2069510249 hasConceptScore W2069510249C519581460 @default.
• W2069510249 hasConceptScore W2069510249C555293320 @default.
• W2069510249 hasConceptScore W2069510249C71924100 @default.
• W2069510249 hasIssue "2" @default.
• W2069510249 hasLocation W20695102491 @default.
• W2069510249 hasLocation W20695102492 @default.
• W2069510249 hasOpenAccess W2069510249 @default.
• W2069510249 hasPrimaryLocation W20695102491 @default.
• W2069510249 hasRelatedWork W1995071802 @default.
• W2069510249 hasRelatedWork W2011709829 @default.
• W2069510249 hasRelatedWork W2037374312 @default.
• W2069510249 hasRelatedWork W2055342276 @default.
• W2069510249 hasRelatedWork W2069510249 @default.
• W2069510249 hasRelatedWork W2092993950 @default.
• W2069510249 hasRelatedWork W2095626059 @default.
• W2069510249 hasRelatedWork W2140892006 @default.

• next